Synta Pharmaceuticals - Research & Manufacturing Laboratory

Lexington, Massachusetts, USA

Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases. BDG was pleased to work with the Synta Team to help them plan the strategic expansion of their research and manufacturing facilities. Beyond the renovation and expansion of the labs, there was a desire to integrate their corporate branding strategy throughout the offices and labs. Exhibit graphics were used to tell their story to customers, investors, and for the recruiting of new employees.

In 2016 Synta Pharmaceuticals merged with Madrigal Pharmaceuticals to create a leading Cardiovascular-Metabolic Diseases and Non-Alcoholic Steatohepatitis (NASH) Company.

˅ Project Imagery ˅